Healthcare News
Semaglutide and tirzepatide lead to better blood sugar control and weight loss in type 1 diabetes, study finds
Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who are living with overweight or obesity, research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) held in Madrid, Spain (9–13 September) has found.
Good sleep habits important for overweight adults, study suggests
New research from Oregon Health & Science University reveals negative health consequences for people who are overweight and ignore their body's signals to sleep at night.
Weight-loss jabs linked to lower cancer risk compared with insulin new study
Researchers in the US wanted to know if weight-loss drugs known as GLP-1 agonists reduced the risk of people getting any of the 13 cancers associated with obesity. Their results were recently published in JAMA Network Open.
Weight loss linked to improved mood and reduced risk-taking in obese individuals
People who are severely overweight (obese) not only exhibit altered risk behavior, but also changes in their metabolism and psyche.
Trying to limit calories? Skip the dip, researchers advise
The chips and dip together yielded a 77% greater caloric intake, and a faster total eating rate compared to the "just chips, no-dip" control.
